VIRGINIA RETIREMENT SYSTEMS ET Al Sells 134,507 Shares of DaVita Inc. $DVA

Posted by Geri Gentry on May 16th, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al lessened its stake in DaVita Inc. (NYSE:DVA – Free Report) by 88.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,900 shares of the company’s stock after selling 134,507 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in DaVita were worth $1,920,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in DVA. Elevation Wealth Partners LLC grew its position in DaVita by 147.3% in the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock worth $31,000 after purchasing an additional 165 shares during the period. Canada Pension Plan Investment Board bought a new stake in DaVita in the 2nd quarter worth approximately $43,000. iSAM Funds UK Ltd bought a new stake in DaVita in the 3rd quarter worth approximately $46,000. Stance Capital LLC bought a new stake in DaVita in the 3rd quarter worth approximately $47,000. Finally, Camelot Portfolios LLC bought a new stake in DaVita in the 4th quarter worth approximately $57,000. Institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

Shares of DaVita stock opened at $199.43 on Friday. The company’s fifty day simple moving average is $158.38 and its 200-day simple moving average is $135.58. The stock has a market capitalization of $12.80 billion, a PE ratio of 18.50, a P/E/G ratio of 0.63 and a beta of 0.84. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $202.69.

DaVita (NYSE:DVA – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.33 by $0.54. The business had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The company’s revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the company posted $2.00 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts anticipate that DaVita Inc. will post 15.07 EPS for the current year.

Insider Buying and Selling at DaVita

In related news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the transaction, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on DVA shares. Barclays lifted their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. TD Cowen lifted their target price on shares of DaVita from $144.00 to $201.00 and gave the stock a “hold” rating in a research report on Monday. Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. Finally, Truist Financial lifted their price target on shares of DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a research note on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $199.17.

Get Our Latest Report on DVA

About DaVita

(Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.